Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to equity ratio high or low?
The debt to equity ratio of -7.33 is 3341% below its 5-year average of -0.21, near the high end of its 5-year range (-42.92–1.42).
As of the fiscal period ended Tuesday, June 30, 2026. 350.87% below its 12-month average of -1.63.
Reported quarterly debt to equity ratio; no daily interpolation. Q2 FY2026 (2026-06-30): -7.33.
DEBT TO EQUITY RATIO
-7.33
DEBT TO EQUITY RATIO AVG TTM
-1.63
DEBT TO EQUITY RATIO AVG 3Y
-0.35
DEBT TO EQUITY RATIO AVG 5Y
-0.21
DEBT TO EQUITY RATIO AVG 10Y
N/A
DEBT TO EQUITY RATIO AVG 15Y
N/A
DEBT TO EQUITY RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-350.87%
CURRENT VS 3Y AVG
-2013.55%
CURRENT VS 5Y AVG
-3340.61%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.11
median of 766 covered companies
CURRENT VS SECTOR MEDIAN
-6763.10%
vs the sector median at left
NRx Pharmaceuticals, Inc.
Market Cap
$126.87M
Debt to Equity Ratio
-7.33
TTM Avg
-1.63
3Y Avg
-0.35
5Y Avg
-0.21
Market Cap
$128.93M
Debt to Equity Ratio
1.56
TTM Avg
0.26
3Y Avg
0.20
5Y Avg
0.16
Market Cap
$124.90M
Debt to Equity Ratio
0.01
TTM Avg
0.03
3Y Avg
0.04
5Y Avg
0.02
Market Cap
$122.91M
Debt to Equity Ratio
0.02
TTM Avg
0.02
3Y Avg
0.02
5Y Avg
0.01
Market Cap
$133.01M
Debt to Equity Ratio
1.69
TTM Avg
0.90
3Y Avg
0.77
5Y Avg
0.69
Market Cap
$120.92M
Debt to Equity Ratio
0.14
TTM Avg
0.14
3Y Avg
0.16
5Y Avg
0.14
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NRx Pharmaceuticals, Inc. (NRXP) | $126.87M | -7.33 | -1.63 | -0.35 | -0.21 |
| Entera Bio Ltd. (ENTX)vs › | $126.92M | 0.06 | 0.04 | 0.03 | 0.03 |
| Pyxis Oncology, Inc. (PYXS)vs › | $128.93M | 1.56 | 0.26 | 0.20 | 0.16 |
| Tonix Pharmaceuticals Holding Corp. (TNXP)vs › | $124.90M | 0.01 | 0.03 | 0.04 | 0.02 |
| TuHURA Biosciences, Inc. (HURA)vs › | $122.91M | 0.02 | 0.02 | 0.02 | 0.01 |
| Health Catalyst, Inc. (HCAT)vs › | $133.01M | 1.69 | 0.90 | 0.77 | 0.69 |
| Seer, Inc. (SEER)vs › | $121.78M | 0.10 | 0.08 | 0.08 | 0.06 |
| Cibus, Inc. (CBUS)vs › | $121.37M | 2.21 | 6.33 | 3.67 | 2.74 |
| enGene Holdings Inc. (ENGN)vs › | $120.92M | 0.14 | 0.14 | 0.16 | 0.14 |
| AirSculpt Technologies, Inc. (AIRS)vs › | $133.68M | 0.67 | 1.14 | 1.25 | 1.10 |
Debt/Equity
-7.33
Current Ratio
0.86
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2026-06-30 | -7.33 |
| 2026-03-31 | -0.07 |
| 2025-12-31 | -0.04 |
| 2025-09-30 | -0.40 |
| 2025-06-30 | -0.29 |
| 2025-03-31 | -0.33 |
| 2024-12-31 | -0.28 |
| 2024-09-30 | -0.35 |
| 2024-06-30 | -0.47 |
| 2024-03-31 | -0.45 |
| 2023-12-31 | -0.78 |
| 2023-09-30 | -1.62 |
| 2023-06-30 | -4.52 |
| 2023-03-31 | -42.92 |
| 2022-12-31 | 1.42 |
| 2022-09-30 | 0.00 |
| 2022-06-30 | 0.00 |
| 2022-03-31 | 0.02 |
| 2021-12-31 | 0.02 |
| 2021-09-30 | 0.06 |
| 2021-06-30 | -0.04 |
| 2021-03-31 | 2.34 |
| 2020-12-31 | -0.02 |
| 2020-09-30 | 0.77 |
| 2020-06-30 | 0.65 |
| 2020-03-31 | 0.58 |
| 2019-12-31 | 0.07 |
| 2019-09-30 | 0.05 |
| 2019-06-30 | 0.03 |
| 2019-03-31 | 0.02 |
| 2018-12-31 | 0.01 |
| 2018-09-30 | 4.71 |
| 2018-06-30 | 2.94 |
| 2018-03-31 | 0.88 |
| 2017-12-31 | 0.00 |
| 2017-09-30 | 4.20 |
